Status:
RECRUITING
French Cohort of Myocardial Infarction Evaluation
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Novartis
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless...
Detailed Description
The FRENCHIE registry is a French multicenter prospective observational study. All the eligible consecutive patients admitted within 48 hours after symptom onset in a cardiac ICU for an acute myocardi...
Eligibility Criteria
Inclusion
- Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :
- Symptoms compatible with myocardial ischemia
- Appearance of pathological Q waves
- ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)
- Written consent.
- Covered by French medical insurance ("Sécurité Sociale")
Exclusion
- Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
- AMI diagnosis invalidated in favor of another diagnosis
Key Trial Info
Start Date :
March 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 22 2049
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT04050956
Start Date
March 11 2019
End Date
March 22 2049
Last Update
June 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Bichat, AP-HP
Paris, France, 75018